PLCE1 rs2274223 Polymorphism and Susceptibility to Esophageal Cancer: a Meta-analysis

  • Guo, Li-Yan (Department of Public Health, Jining Medical University) ;
  • Yang, Ning (Department of Physical Examination Center, the Affiliated Hospital of Jining Medical University) ;
  • Hu, Die (Department of Public Health, Jining Medical University) ;
  • Zhao, Xia (Department of Cardio-Thoracic Surgery, The First People's Hospital of Jining City) ;
  • Feng, Bing (International Cooperation Department, Jining Medical University) ;
  • Zhang, Yan (Department of Public Health, Jining Medical University) ;
  • Zhai, Min (Department of Public Health, Jining Medical University)
  • Published : 2014.11.28


Purpose: To investigate and study the relationship between the PLCE1 rs2274223 gene polymorphism and susceptibility to esophageal cancer by meta-analysis. Materials and Methods: The literature was searched in Wanfang, CNKI, PubMed, CBM, Web of Science, MEDLINE, EMBASE, Springer, Elsevier and Cochrane databases from the date of January $1^{st}$ 2004 to April $1^{st}$ 2014 to collect case-control studies on the PLCE1 polymorphism and susceptibility to esophageal cancer. For the population genotype distributions of both esophagus cancer and control groups, their odds ratios (ORs) and 95% confidence intervals (CIs) were taken as effect indexes. Disqualified studies were excluded. Odds ratios of PLCE1 rs2274223 genotype distributions in the group of patients with esophageal cancer and the group of healthy control were calculated. The metaanalysis software, RevMan5.0, was applied for heterogeneity test, pooled OR and 95% confidence intervals. Sensitivity analysis and publication bias were also explored. Results: A total of twelve case-control studies were included, covering a total of 9, 912 esophageal cancer cases and 13, 023 controls were included. The pooled odds ratio of PLCE1 rs2274223 genotype GA vs AA was 1.29 (95%CI=1.17~1.43), p<0.01, GG vs AA was 1.65 (95%CI=1.32~2.05), p<0.01, GG/GA vs AA was 1.30 (95%CI=1.16~1.46), p<0.01 and GG vs GA/AA was 1.48 (95%CI=1.22~1.80), p<0.01. The PLCE1 rs2274223 polymorphism was thus associated with risk of esophageal cancer in all genetic models. In the stratified analysis by ethnicity, and source of controls, no significantly increased risk was observed for white persons. There was no obvious publication bias detected. Conclusions: This meta-analysis showed there was a significantly association between PLCE1 rs2274223 polymorphism and esophageal cancer in yellow race populations. Due to some minor limitations, our findings should be confirmed in further studies.


Supported by : Jining Medical University


  1. Abnet CC, Freedman ND, Hu N, et al (2012). Genome-wide association studies of gastric adenocarcinoma and esophageal squamous cell carcinoma identify a shared susceptibility locus in PLCE1 at 10q23. Nat Genet, 44, 1090-7.
  2. Bye H, Prescott N J (2012). Distinct genetic association at the PLCE1 locus with oesophageal squamous cell carcinoma in the South African population. Carcinogenesis, 33, 2155-61.
  3. Chen YZ, Cui XB, Pang XL, et al (2013). Relationship between rs2274223 and rs3765524 polymorphisms of PLCE1 and risk of esophageal squamous cell carcinoma in a Kazakh Chinese population. Chin J Pathol, 42, 795-801.
  4. Cui XB, Chen YZ, Liu L, et al (2014). Heterozygote of PLCE1 rs2274223 increases susceptibility to human papilloma virus infection in patients with esophageal carcinoma among the kazakh populations. J Medical Virol, 86, 608-17.
  5. Cui XB, Chen YZ, Pang XL, et al (2013). Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population. Science Direct, 530, 315-22.
  6. Duan F, Xie W, Cui L, et al (2013). Novel functional variants locus in PLCE1 and susceptibility to esophageal squamous cell carcinoma: based on published genome-wide association studies in a central Chinese population. Cancer Epidemiol, 37, 647-52.
  7. Dura P, Bregitha CV, Te Morsche RH, et al (2012). GWAS-uncovered SNPs in PLCE1 and RFT2 genes are not implicated in Dutch esophageal adenocarcinoma and squamous cell carcinoma etiology. Eur J Cancer Prev, 61, 69-90.
  8. Ding JH, Wu JZ, Li SP, et al (2011). Polymorphisms of aldehyde dehydrogenase- 2 genotypes and alcohol consumption for the susceptibility of the liver cancer, stomach cancer and esophageal cancer. Jiangsu Inst Cancer Res, 38, 579-83.
  9. Gbadegesin R, Bartkowiak B, Lavin P J (2009). Exclusion of homozygous PLCE1 (NPHS3) mutations in 69 families with idiopathic and hereditary FSGS. Pediatr Nephrol, 24, 281-5.
  10. Gu HY, Ding GW, Zhang WB, et al (2013). Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Springer Science Business Media, 39, 9105-11.
  11. Han ST, Wei WQ, Zhang ST, et al (2012). Risk factors of esophageal cancer in a high-risk area in China. Chinese General Practice, 15, 3745-8.
  12. Hu HC, Yang JM, Sun YH, et al (2012). Putatively functional PLCE1 variants and susceptibility to esophageal squamous cell carcinoma (ESCC): A case-control study in eastern Chinese populations. Ann Surg Oncol, 19, 2403-10.
  13. Little J, Higgins JP, Ioannidis JP, et al (2009). Strengthening the reporting of genetic association studies (STREGA) an extension of the STROBE statement. Genet Epidemiol, 33, 581-98.
  14. Ma HX, Wang LE, Liu ZS (2011). Association between novel PLCE1 variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck. BMC Cancer, 11, 1105-9.
  15. Mai RQ, Cheng YB, Huang YS, et al (2012). Esophageal squamous cell carcinoma and gastric cardia: A denocarcinoma shared susceptibility locus in PLCE1: a meta-analysis. Plos One, 8, 69-214.
  16. Palmer A J, Lochhead P, Hold G L, et al (2012). Genetic variation in C20orf54, PLCE1 and MUC1 and risk of upper gastrointestinal cancers in caucasian populations. Eur J Cancer Prev, 21, 541-4.
  17. Pan QF, Chen YZ, Liu CX, et al (2012). Real-time fluorescent quantitative PCR assay for detection of ESCC tissue the PLCE1 gene expression. J Nongken Medicine, 34, 385-8.
  18. Peng XE, Shi XS, Zhou ZJ, et al (2004). Relationship between esophageal cancer and interactions of genes and environmental factors. World Chin J Digestol, 12, 2531-3.
  19. Piao JM, Shin MH, Kim HN, et al (2013). Replication of results of genome-wide association studies on esophageal squamous cell carcinoma susceptibility loci in a Korean population. Dis Esophagus, 1-4.
  20. Song X, Zhou FY, Zhang LQ, et al (2012). Correlation of PLCE1 gene polymorphism in the smoker/non-smokers, drinking /non-drinking, and BMI subgroups with esophageal squamous cell carcinoma. J Henan University, 31, 186-90.
  21. Tang WF, Sun B, Gu HY, et al (2011). COX-2 polymorphism and susceptibility to esophageal cancer: A meta-analysis. Chin J Evid-based Med, 11, 1391-4.
  22. Wang GL, Yan M, Ba YF, et al (2011). MTHFR C677T polymorphism and esophageal cancer susceptibility: a meta-analysis. Modern Preventive Medicine, 38, 1103-7.
  23. Wang J, Dong WG, Guo XF, et al (2013). Association between polymorphisms of epidermal growth factor 61 and susceptibility of esophageal carcinoma: A meta-analysis. Chin J Evid-based Med, 13, 1209-14.
  24. Wang LD, Bi XL, Song X, et al (2013). A Sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis. Molecular Carcinogenesis, 52, 80-6.
  25. Wei F, Han P, Luo K, et al (2013). P27val109Gly polymorphism and cancer risk: a systematic review and meta-analysis. Chin J Cancer Prev Treat, 20, 1360-5.
  26. Wu KS, Li K (2006). Meta-analysis on the relationship between genetic polymorphism of cytochrome P450 2E1 and the susceptibility to esophageal cancer. J Basic Clinical Oncol, 19, 13-6.
  27. Yang JZ, Wang JS, Ji AF, et al (2013). p53 polymorphisms and susceptibility to esophageal cancer in Chinese population: a meta-analysis. Modern Preventive Medicine, 40, 808-14.
  28. Yu S, Guan TP, Tao HQ (2013). Research progress in the relationship between PLCE1 and gastrointestinal cancers. J Chinese Oncol, 19, 809-13.
  29. Zhao GX, Chai YR, Wang P, et al (2011). Meta-analysis on the relationship between genetic polymorphism of GSTM1and the risk to esophageal cancer. Chin J Public Health, 27, 241-3.
  30. Zhao L, Wei ZB, Yang CQ, et al (2014). Effects of PLCE1 gene silencing by RNA interference on cell cycling and apoptosis in esophageal carcinomacells. Asian Pac J Cancer Prev, 15, 5437-42.
  31. Zhao XK, Zhou FY, Zhang LQ, et al (2012). Expression of PLCE1 protein in esophageal multistage carcinogenesis. J Henan University, 31, 203-5.
  32. Zhou RM, Li Y, Wan N, et al (2012). PLC-$\varepsilon{1}$ gene polymorphisms significantly enhance the risk of esophageal squamous cell carcinoma in individuals with a family history of upper gastrointestinal cancers. Arch Med Res, 43, 578-84.

Cited by

  1. PLCE1 Gene in Esophageal Cancer and Interaction with Environmental Factors vol.16, pp.7, 2015,
  2. Genetic Variations in Phospholipase C-epsilon 1 (PLCE1) and Susceptibility to Colorectal Cancer Risk vol.54, pp.6, 2016,
  3. Promotes the Invasion and Migration of Esophageal Cancer Cells by Up-Regulating the PKCα/NF-κB Pathway vol.59, pp.10, 2018,
  4. Cumulative evidence for association between genetic polymorphisms and esophageal cancer susceptibility: A review with evidence from meta-analysis and genome-wide association studies pp.20457634, 2019,